Article
Author(s):
An awards ceremony at the Pharmapack Europe exhibition and conference in Paris recognized pioneering packaging innovations that have significantly contributed to improving user safety, ease of use, and other health care needs.
Pharmapack Europe has recognized 8 pioneering packaging innovations.1 Announced in Paris, the 2020 Pharmapack Awards winners included Safe’n’Spray, a smart drug delivery device with reusable electronic locking unit and fingerprint identification that prevents overdosing,2 and the eco-designed Respimat reusable inhaler device.3
Winners were recognized during the Pharmapack Europe exhibition and conference, an annual event for pharmaceutical packaging, drug delivery, medical devices, and machinery.4 They were chosen in categories that include Exhibitor Innovations, Patient-Centric Design, and Eco-Design. They were honored for contributions to improving patient/user safety, ease of use, ecology awareness, patient awareness, and cost efficiency.
As a pharmacist, your insight has a direct effect on patient outcomes. Help drive medicine forward with your opinions. Participate in a quick survey of OTC products for a chance to win a $1,000 Visa gift card. Vote now by clicking here: https://hraresearchnetwork.com/wix/p6499706.aspx?hPTsource=5
The awards were divided into 2 categories, the first being Exhibitor Innovations which saw 6 winners.5
Marc Hämel, CEO of Nemera, noted that the company was proud to receive the award for Safe’n’Spray.2
“According to the World Health Organization, overdose deaths contribute to between roughly a third and a half of all drug-related deaths, which are attributable in most cases to opioids. Receiving the Pharmapack ‘Best Innovation in Drug Delivery Device’ Award is a great recognition for all our teams working every day to improve patients’ lives with innovative ideas,” Hämel said, in a prepared statement.
In the Health Product category, there are 2 winners. The awards went to:5
The award-winning Respimat design was developed as a result of patient feedback, according to BI. The company expects to reduce plastic waste by 776 tons in the next 5 years, and reduce carbon dioxide emissions by 14,300 tons, compared to most disposable inhaler devices.3
“A very important aim of Boehringer Ingelheim is to lower greenhouse gasses and reduce waste, so we’re proud to be recognized for our efforts in this area,” said Dr Paola Casarosa, Head of Global Therapeutic Areas, BI, in a prepared statement.3
REFERENCES